A new study published in The American Journal of Public Health by researchers at The Fenway Institute estimated the prevalence of exposure to gender identity conversion therapy, attempts to change a person’s gender identity from transgender to cisgender. Study authors …
We are pleased to announce that Fenway Institute Research Scientist Katie Biello, PhD, MPH, has been selected to receive a National Institutes of Health (NIH) Sexual & Gender Minority Early Stage Investigator Award. As described by the NIH Sexual & …
The Division of Education and Training at The Fenway Institute has been awarded a new grant from the Health Resources and Services Administration (HRSA) Bureau of Primary Health Care (BPHC) to lead technical assistance and implementation of HIV pre-exposure prophylaxis …
Fenway Institute faculty members will be presenting at this year’s International AIDS Society (IAS) Conference in Mexico City July 21-24. The IAS Conference is the largest open scientific conference on HIV science in the world.
Kenneth Mayer, MD, Medical Research …
BOSTON, June 25, 2019—In honor of LGBT Pride Month, the Fenway Institute released a series of three issue briefs to help healthcare organizations collect sexual orientation and gender identity (SOGI) data from patients to improve quality of care and reduce …
The Fenway Institute is seeking to hire a professional production company to produce 12 interactive learning modules that explore how certain interventions can improve the health outcomes of people living with HIV. Each module will take about 45-60 minutes for …
The 7th Annual MGH Public and Community Psychiatry Symposium was held at MGH on March 27th, 2019. The focus of this year’s symposium was ‘Health Equity for Transgender and Non-binary Communities,’ and the day was organized by Alex Keuroghlian, Director …
The Fenway Institute hosted its inaugural Advancing Excellence for Sexual and Gender Minority Health Conference this past weekend at the Boston Seaport Hotel. The conference was a great success, with 250 attendees from across the US and beyond coming together …
A new study to observe adherence for the HIV prevention drug TRUVADA for PrEP (Pre-Exposure Prophylaxis) among Fenway Health patients will use the ID-Cap System by etectRx, a state-of-the-art ingestion event monitoring technology.
The study will be conducted …
The Fenway Institute is excited to announce that our vaccine study, HVTN124, has finished enrollment.
Vaccines have had a huge impact on the health of the global population. They are safe and effective when it comes to preventing diseases, like …
